Oct 23, 2020 09:15AM
Oct 23, 2020 09:15AM
Oct 14, 2020 08:33AM
Sep 24, 2020 06:24AM
Sep 21, 2020 10:00AM
Sep 18, 2020 06:48AM
Sep 17, 2020 02:45PM MERGER ALERT – MFAC, IMMU, and MKGI: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
Sep 15, 2020 07:06AM
Sep 14, 2020 12:58PM
Sep 14, 2020 11:55AM
Sep 14, 2020 09:30AM
Sep 14, 2020 07:02AM
Sep 14, 2020 06:59AM
Sep 13, 2020 08:03PM Gilead Sciences (GILD) to Acquire Immunomedics (IMMU) for $21 Billion
Sep 13, 2020 03:00PM
Sep 12, 2020 03:17PM
Apr 7, 2020 09:28AM
Apr 7, 2020 09:28AM
Apr 7, 2020 08:03AM
Apr 7, 2020 08:00AM
Apr 7, 2020 08:00AM FDA GRANTS FAST TRACK DESIGNATION TO SACITUZUMAB GOVITECAN FOR NEOADJUVANT/ADJUVANT METASTATIC UROTHELIAL CANCER
Apr 6, 2020 08:06AM
Apr 6, 2020 08:00AM
Apr 6, 2020 08:00AM
Apr 6, 2020 07:51AM
Apr 6, 2020 07:50AM
Apr 6, 2020 07:50AM
Apr 3, 2020 05:00PM IMMUNOMEDICS TO HOST CONFERENCE CALL AND WEBCAST ON APRIL 6, 2020 TO PROVIDE CLINICAL AND CORPORATE UPDATE
Apr 3, 2020 05:00PM
Mar 25, 2020 08:03AM
Mar 25, 2020 08:00AM
Mar 25, 2020 08:00AM
Feb 27, 2020 04:10PM
Feb 27, 2020 04:10PM
Feb 27, 2020 04:00PM Immunomedics Reports Fourth Quarter and Full Year 2019 Results and Provides Corporate Update
Feb 27, 2020 04:00PM
Feb 25, 2020 08:00AM
Feb 25, 2020 08:00AM
Feb 20, 2020 08:00AM
Feb 20, 2020 08:00AM
Feb 14, 2020 08:05AM
Feb 14, 2020 08:00AM Immunomedics Appoints Dr. Loretta Itri Chief Medical Officer
Feb 14, 2020 08:00AM
Feb 6, 2020 08:00AM
Feb 6, 2020 08:00AM
Feb 6, 2020 08:00AM
Dec 26, 2019 08:01AM
Dec 26, 2019 08:00AM
Dec 26, 2019 08:00AM Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer
Dec 3, 2019 08:01AM

1,155,043 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All